p53 Mutation and MDM2 Amplification in Human Soft Tissue Sarcomas

Cancer Research

Volumn 53, Issue 10, 1993, Pages 2231-2234

  Hill, David E ^c   Burrell, Marilee ^c   Oliner, Jonathan D ^a   Sidransky, David ^a   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Oncogene Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SOFT TISSUE SARCOMA;

ANIMAL; ANTIBODIES, MONOCLONAL; BLOTTING, SOUTHERN; CELL DIVISION; DEOXYRIBONUCLEASE ECORI; DERMATOFIBROMA; DNA PROBES; DNA, NEOPLASM; EXONS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM PROTEINS; POINT MUTATION; SARCOMA; SOFT TISSUE NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027232042     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hollstein, M. Sidransky, D. Vogelstcin, B. and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Toguchida, J. Yamaguchi, T. Ritchie, B. Beauchamp, T.L. Dayton, S.H. Herrera, G.E. Yamamuro, T. Kotoura, Y. Sasaki, M.S. Little, J.B. Weichselbaum, R.R. Ishizaki, K. and Yandell, D.W. Mutation spectrum of the p. 3 gene in bone and soft tissue sarcomas. Cancer Res. 52: 6194-6199, 1992.
3. Soini, Y. Vahakangas, K. Nuorva, K. Kamel, D. Lane, D.P. and Paakko, P. p. 3 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. J. Pathol. 168: 29-33, 1992.
4. Ueda, Y. Dockhom-Dwomiczak, B. Blasius, S. Mellin, W. Wuisman, P. Bocker, W. and Roessner, A. Analysis of mutant p. 3 protein in osteosarcomas and other malignant and benign lesions of bone. J. Cancer Res. Clin. Oncol. 119: 172-178, 1993.
5. Andreassen, O. Oord, T. Hovig, E. Holm, R. Flørenes, V.A. Nesland, J.M. Myklebost, O. Høie, J. Bruland, O.S. Borresen, A.L. and Fodstad, O. p. 3 abnormalities in different subtypes of human sarcomas. Cancer Res. 53: 468-471, 1993.
6. Dei Tos, A.P. Doglioni, C. Laurino, L. Barbareschi, M. and Fletcher, C.D.M. p. 3 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology, 22: 45-50, 1993.
7. Momand, J. Zambetti, G.P. Olson, D.C. George, D. and Levine, A.J. The MDM2 oncogene product forms a complex with the p. 3 protein and inhibits p. 3-mediated transactivatíon. Cell, 691: 1237-1245, 1992.
8. Oliner, J.D. Kinzler, K.W. Meltzer, P.S. George, D.L. and Vogelstein, B. Amplification of a gene encoding a p. 3-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
9. Roberts, W M, Douglass, E.C. Peiper, S.C. Houghton, P.J. and Look, A.T. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49: 5407-5413, 1989.
10. Baker, S.J. Preisinger, A.C. Jessup, J.M. Paraskeva, C. Markowitz, S. Willson, J.K.V. Hamilton, S.R. and Vogelstein, B. p. 3 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50: 7717-7720, 1990.
11. Baker, S.J. Markowitz, S. Fearon, E.R. Willson, J.K.V. and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p. 3. Science (Washington DC), 249: 912-919, 1990.
12. Baker, S.J. Fearon, E.R. Nigro, J.M. Hamilton, S.R. Preisinger, A.C. Jessup, J.M. van Tuinen, P. Ledbetter, D.H. Barker, D.F. Nakamura, Y. White, R. and Vogelstein, B. Chromosome 17 deletions and p. 3 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
13. Feinberg, A.P. and Vogelstein, B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13, 1983.
14. McKenzie, S.J. Marks, P.J. Lam, T. Morgan, J. Panicali, D.L. Trimpe, K.L. and Carney, W.P. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p. 85. Oncogene, 4: 543-548, 1989.
15. Smith, K.J. Johnson, K.A. Bryan, T.M. Hill, D.E. Markowtiz, S. Willson, J.K.V. Paraskeva, C. Petersen, G.M. Hamilton, S.R. Vogelstein, B. and Kinzler, K.W. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2846-2850, 1993.
16. Bodner, S.M. Minna, J.D. Jensen, S.M. Damico, D. Carbone, D. Mitsudomi, T. Fedorko, J. Buchhagen, D.L. Nau, M.M. Gazdar, A.F. and Linnoila, R.I. Expression of mutant p. 3 proteins in lung cancer correlates with the class of p. 3 gene mutation. Oncogene, 7: 743-749, 1992.
17. Barak, Y. Juven, T. Haffner, R. and Oren, M. MDM2 expression is induced by wild type p. 3 activity. EMBO J. 12: 461-468, 1993.
18. Fakharzadeh, S.S. Trusko, S.P. and George, D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569, 1991.
19. Finlay, C.A. The MDM2 oncogene can overcome wild-type p. 3 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306, 1993.
20. Vogelstein, B. and Kinzler, K. W p. 3 function and dysfunction. Cell, 70: 523-526, 1992.
21. Oliner, J.D. Pietenpol, J.A. Thiagalingam, S. Gyuris, J. Kinzler, K.W. and Vogelstein, B. MDM2 conceals the activation domain of p. 3. Nature (Lond.), in press, 1993.
22. Werness, B.A. Levine, A.J. and Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p. 3. Science (Washington DC), 248: 76-79, 1990.
23. Mietz, J.A. Unger, T. Huibregtse, J.M. and Howley, P.M. The transcriptional transactivatíon function of wild-type-p. 3 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11: 5013-5020, 1992.
24. Crook, T. Farthing, A. and Vousden, K. HPV-16 and cervical intraepithelial neoplasia. Lancet, 339: 1231, 1992.
25. Fujita, M. Inoue, M. Tanizawa, O. Iwamoto, S. and Enomoto, T. Alterations of the p. 3 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res. 52: 5323-5328, 1992.